Home › Cancer (all types) › New Jersey › Paterson
Cancer (all types) clinical trials in Paterson, NJ
4 studies for Cancer (all types) are looking for participants at sites in and around Paterson (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Prospective Study to Assess a Diagnostic Aid for Cancer
RecruitingObservational study
- Oncology Hematology Specialists, Mountain Lakes · 14 mi away
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RecruitingPhase 3
- The Valley Hospital, Inc., Paramus · 5 mi away
Project: Every Child for Younger Patients With Cancer
RecruitingObservational study
- Saint Joseph's Regional Medical Center, Paterson
Caris Biorepository Research Protocol
RecruitingObservational studyHealthy volunteers welcome
- ObjectiveHealth - Premier Health Research, Sparta · 26 mi away
About Cancer (all types)
If you or someone you love has been diagnosed with cancer, learn about diagnosis, treatment, risk factors, coping and much more.
More about Cancer (all types) on MedlinePlus
Cancer (all types) trials in other cities
- Houston, TX121 studies
- New York City, NY110 studies
- Boston, MA86 studies
- Los Angeles, CA73 studies
- Nashville, TN65 studies
- Philadelphia, PA59 studies
- Durham, NC58 studies
- Washington, DC58 studies
- Chicago, IL51 studies
- Seattle, WA49 studies
- Atlanta, GA49 studies
- Arlington, VA48 studies
Other studies in Paterson
- Breast Cancer7 studies
- Acute Myeloid Leukemia7 studies
- Non-Small Cell Lung Cancer6 studies
- Lung Cancer5 studies
- Melanoma5 studies
- Burkitt Lymphoma4 studies
- Heart Failure4 studies
- Aortic Valve Stenosis4 studies
- Steatotic Liver Disease3 studies
- Coronary Artery Disease3 studies
- Myeloproliferative Neoplasms3 studies
- Prostate Cancer3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.